Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Besponsa 1mg powder for concentrate for solution for infusion vials (Pfizer Ltd) |
| BNF code | 0801050CEBBAAAA |
| Virtual Medicinal Product | Inotuzumab ozogamicin 1mg powder for solution for infusion vials |
| Name | Besponsa 1mg powder for concentrate for solution for infusion vials |
| Abbreviated name | Besponsa 1mg pdr for concentrate for inf |
| Date of name applicability | 6 Mar 2018 |
| Previous name | Besponsa 1mg powder for solution for infusion vials |
| Supplier | Pfizer Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Besponsa 1mg powder for concentrate for solution for infusion vials (Pfizer Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_12.1.0_20251208000001, imported on 9th December 2025 at 04:06:46.